Mr. Stanton J. Rowe, also known as Stan, now CEO of the NXT Biomedical Incubator has been the Chief Scientific Officer of Edwards Lifesciences Corp. since 2008 and serves as its Corporate Vice President of Advanced Technology. Mr. Rowe served as a Scientific Advisor at Ascent Biomedical Ventures. He Founded Percutaneous Valve Technologies (sold to Edwards). Mr. Rowe served as the President and Chief Executive Officer of Percutaneous Valve Technologies Inc. (PVT). He served as the Corporate Vice President of Business Development and Strategic Planning at Datascope Corp. Prior to this, Mr. Rowe served as a Vice President of Business Development at Johnson & Johnson's Interventional Systems Division (JJIS), responsible for Johnson & Johnson's coronary stent development efforts. At JJIS and the related Cordis Corporation, he held a variety of positions with increasing levels of responsibility, including heading Johnson & Johnson's Business Development, Advanced Technology, Worldwide Clinical Research and Marketing groups. Mr. Rowe joined Cordis after having held several positions in product management for various medical device companies. He serves as a Director of InSeal Medical Ltd. Mr. Rowe also serves as Director of Remon Medical Ltd. He serves as a Board Member of NeuralAnalytics and the Discovery Science Center in Orange County. He serves as a Director of Zift Medical, LLC. He served as a Director of Biomerix Corporation. He holds a Bachelor’s Degree from the University of Alabama.
Medical Innovation Exchange (MIx) is an organization of professionals and innovators in the medical technology industry. The goal of the organization is to foster curiosity and facilitate collaboration in healthcare. We provide a high energy, low stress environment for those looking to share knowledge and become part of a meaningful community.
Onshape is a next-generation SaaS design platform that speeds up product development. It’s an all-in-one system that combines CAD, release management, workflow, collaboration, analytics, admin tools, and an API with more than 50 engineering applications. Onshape helps extended design teams work together faster and helps executives make better business decisions with real-time analytics and unprecedented visibility into their company’s design and manufacturing processes. Founded in 2012, Onshape was acquired by PTC in November 2019 and will operate as a SaaS business unit within the company.
IntuitiveX is a life science consulting firm that specializes in supporting early and growth-stage companies and assisting international companies with commercializing life sciences related technologies within the U.S. Their consulting team is comprised of life science entrepreneurs, physicians, investors, and innovators who bring a combined 100+ years of experience in R&D, Clinical, Surgical, IP Strategy, Prototyping, Product Development, and Commercialization. Whether guidance is needed in one stage or throughout the process from concept to commercialization, their team is readily available to identify, prioritize, and support your specific needs.
Tuesday, February 23, 2021
6:30PM - 8:00PM
$5 Early Bird Tickets (Qty = 25 available for purchase up to two weeks prior to event)
$10 Regular Admission Tickets (Qty = 75 available for purchase up to start of the event)Register Now